Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study

J. Chetwood; Y. Ko; A. Pudipeddi; V. Kariyawasam; S. Paramsothy; R. Leong

doi:10.1093/ecco-jcc/jjac190.0786

Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study

J. Chetwood, Y. Ko, A. Pudipeddi, V. Kariyawasam, S. Paramsothy, R. Leong

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P656
Pages (from-to)	i784
Number of pages	1
Journal	Journal of Crohn's and Colitis
Volume	17
Issue number	Supplement 1
DOIs	https://doi.org/10.1093/ecco-jcc/jjac190.0786
Publication status	Published - 2023
Externally published	Yes
Event	18th Congress of the European Crohn's and Colitis Organisation (ECCO) - Copenhagen, Denmark Duration: 1 Mar 2023 → 4 Mar 2023

Access to Document

10.1093/ecco-jcc/jjac190.0786

Cite this

Chetwood, J., Ko, Y., Pudipeddi, A., Kariyawasam, V., Paramsothy, S., & Leong, R. (2023). Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study. Journal of Crohn's and Colitis, 17(Supplement 1), i784. Article P656. https://doi.org/10.1093/ecco-jcc/jjac190.0786

@article{398750d7ab2f444e93154fed62836521,

title = "Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study",

author = "J. Chetwood and Y. Ko and A. Pudipeddi and V. Kariyawasam and S. Paramsothy and R. Leong",

year = "2023",

doi = "10.1093/ecco-jcc/jjac190.0786",

language = "English",

volume = "17",

pages = "i784",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "Supplement 1",

note = "18th Congress of the European Crohn's and Colitis Organisation (ECCO) ; Conference date: 01-03-2023 Through 04-03-2023",

}

Chetwood, J, Ko, Y, Pudipeddi, A, Kariyawasam, V, Paramsothy, S & Leong, R 2023, 'Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study', Journal of Crohn's and Colitis, vol. 17, no. Supplement 1, P656, pp. i784. https://doi.org/10.1093/ecco-jcc/jjac190.0786

Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study. / Chetwood, J.; Ko, Y.; Pudipeddi, A. et al.
In: Journal of Crohn's and Colitis, Vol. 17, No. Supplement 1, P656, 2023, p. i784.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Superior treatment persistence with ustekinumab in biologic-experienced luminal Crohn's disease

T2 - 18th Congress of the European Crohn's and Colitis Organisation (ECCO)

AU - Chetwood, J.

AU - Ko, Y.

AU - Pudipeddi, A.

AU - Kariyawasam, V.

AU - Paramsothy, S.

AU - Leong, R.

PY - 2023

Y1 - 2023

U2 - 10.1093/ecco-jcc/jjac190.0786

DO - 10.1093/ecco-jcc/jjac190.0786

M3 - Meeting abstract

SN - 1873-9946

VL - 17

SP - i784

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - Supplement 1

M1 - P656

Y2 - 1 March 2023 through 4 March 2023

ER -